drug
palonosetron hydrochloride
Marketedupdated 3mo agoby Accord Healthcare Inc
Approvedcommunity read0 votes
all catalysts(0)
nothing on the calendar yet
Trials studying palonosetron hydrochloride
- phase2A Clinical Trial of HRS5580 for Injection Combined With Palonosetron Hydrochloride for the Prevention of Postoperative Nausea and Vomiting
- phase3APF530 or Aloxi (Palonosetron Hydrochloride) Combined With Dexamethasone in Preventing Nausea and Vomiting in Patients Receiving Chemotherapy for Cancer
- phase3To Evaluate the Efficacy and Safety of QLM2010 for Prevention of Chemotherapy-induced Nausea and Vomiting After Highly Emetogenic Chemotherapy.
- phase2Buccal Film Versus IV Injection Palonosetron for Moderately Emetogenic Chemotherapy Induced Nausea and Vomiting
- EP1An Relative Bioavailability Study of BH006 for Injection in Healthy Subjects
- phase3Clinical Study of HR20013 for Injection in Patients With Malignant Solid Tumors
- phase3Netupitant and Palonosetron Hydrochloride in Preventing Chronic Nausea and Vomiting in Patients With Cancer
- —Observational Study on the Use of Akynzeo® in Patients Receiving HEC
News(0)
no news has mentioned this drug yet
Data sources
last refreshed 17m ago
Found something off?
comments(0)
5-min edit window · permanent after that